Vol. 010
Carrier Screening

CARRIER SCREENINGACOG COMMITTEE OPINION #690
【Abstract】
The Committee on Genetics of theAmerican College of Obstetricians andGynecologists released a committee
opinion in March of this year focusing
on “Carrier Screening in the Age ofGenomicMedicine”(CommitteeOpinion #690).
Carrier screening tests help identify
healthy individuals who are carriers of specific recessive genetic disorders and as a result, be atincreased risk to have affected children. Knowledge gained from carrier screening tests allows
prospective parents to plan reproductive testing and methods, or prenatal and postnatal caremanagement according to their risks, beliefs and values.
ACOG has previously advocated for ethnic-based carrier screening—screening only for thoseconditions more prevalent in one’s ethnic group—for preconception and prenatal genetic carrier
evaluation. With ethnic-based carrier screening, the conditions are more focused and selected.
However, ACOG now feels given the increasing complexity of mixed ethnic backgrounds and theadvancement in genetic testing methodology, panethnic screening and expanded carrier
screening are acceptable strategies as well. In other words, it is acceptable for patients toconsider simultaneously screening for multiple genetic conditions that may or may not be
particularly selected based on ethnicity alone. This committee opinion statement also specificallypointed out the risks/benefits/limitations with this approach and gave suggestions on disease
selections.
This newsletter will review the basic concepts and important counseling points related tocarrier screening, as well as introducing panethnic and expanded carrier screening concepts as
highlighted in this issue of committee opinion.

【Discussion】
What are Carriers?
Carriers are people who are healthy but carry a mutation or an abnormal/malfunctioned

GGA Corp. Genetic Counseling Newsletter – Vol. 010
Carrier Screening – ACOG Committee Opinion #690

2

copy of a gene associated with a recessively inherited genetic disorder.
Generally speaking, a person has two copies of every gene—one copy inherited from his/herfather and the other from his/her mother. Recessive disorders are genetic conditions that present
abnormal clinical features when both copies of the disease-causing gene are abnormal or notfunctional. Because carriers have one abnormal copy of the disease-causing gene and a normal copy,
they generally do not have any abnormal developmental or growth problems and are not affectedby the condition. However, they can pass the abnormal copy to their children. If both the motherand the father are carriers, there is a chance that the child inherits both abnormal copies of thegene, i.e. has no normal copy, and be affected by the condition.

What is a Carrier Screening Test?
Carrier screening test is a genetic test, usually through a blood draw or a cheek swab to collectcells containing genetic materials, to determine whether a healthy person is a carrier for a specificcondition or not.

What are the Goals of Carrier Screening Tests?
Although carriers do not have health concerns themselves, they are at increased risk/chance tohave a child affected with that particular condition. Therefore, the goals of carrier screening tests
are to provide meaningful information to parents or prospective parents so they can better
decide on pregnancy plans based on their reproductive risks, beliefs and family plans.

Who should be Offered Carrier Screening Tests?
The tests are most appropriate to be offered to all patients considering pregnancy or are
already pregnant. Pregnancy plans, preconception or prenatal testing options can be arranged
according to the test results.
Couples with consanguinity (blood-related relatives) have increased risk for recessive genetic
conditions and carrier screening tests can be considered.

Should Individuals with a Family History of Genetic Disorder Undergo Carrier Screening Tests?
The ideal first step is to identify the specific diagnosis and the specific disease-causing
genetic mutation in the affected person.
Many different genetic conditions have similar overlapping clinical presentation. Even for thesame condition, there could be more than one type of disease-causing genetic mechanisms. TheThis newsletter is produced and owned by GGA Corp.
Copyrights © GGA Corp. All Rights Reserved.

GGA Corp. Genetic Counseling Newsletter – Vol. 010
Carrier Screening – ACOG Committee Opinion #690

3

disease-causing genetic change may be different for different families and screening at-risk healthy
relatives for the right genetic change is crucial in identifying carriers and reproductive risks. Thus, it
is generally always more effective to first perform genetic testing on the affected family member tofind the disease-causing mutation in the family. Once a mutation is identified, testing of otherat-risk healthy relatives can be done by targeting at this hereditary genetic change. Such strategy ismore precise and specific, less time consuming and costly, and provides a more informative answer.
Without knowledge of the true disease-causing change in the affected relative, while
performing general carrier screen for other healthy family members can lower their carrier risk,
there is a potential risk of miss detecting a true carrier. If the specific familial disease-causing
mutation is not included in the general carrier screening panel, it could result in a

What happens if the Carrier Screening Test
Results are Positive/Abnormal?
A positive/abnormal carrier screening test
result= Patient is a carrier; Offspring may be atincreased risk to be affected
For autosomal recessive conditions:
If a patient screened positive/abnormal foran autosomal recessive genetic condition, thenhis/her reproductive partner should be offeredcarrier screen for the same condition. If bothmembers of a couple are found to be carriers
for the same autosomal recessive condition,
each of their pregnancy is at 1/4 (25%) risk tobe affected.
Prenatal testing through chorionic villus
sampling(CVS)
oramniocentesis,
orpreconception testing using preimplantation
genetic diagnosis (PGD) method can beconsidered to identify fetus/embryos affectedby the condition. Using donor gametes forIf autosomal recessive conditions:false-reassurance test result and a true carrier be missed. A person can still be a carrier since thetrue familial mutation was not in fact tested, and can therefore give birth to an affected child.

Example of prenatal carrier screening strategy.
SMA=Spinal muscular atrophy – an autosomal
recessive condition; FXS=Fragile X syndrome – anX-linked condition.

This newsletter is produced and owned by GGA Corp.
Copyrights © GGA Corp. All Rights Reserved.

GGA Corp. Genetic Counseling Newsletter – Vol. 010
Carrier Screening – ACOG Committee Opinion #690

4

reproduction is an option as well.
For X-linked conditions:
As the disease-causing gene is located on the X chromosome, typically only females would be
carriers (females have two X chromosomes). Males only have one chromosome and will be affectedby the condition if his only copy of the disease-causing gene is defective. Therefore, for X-linked
conditions, carrier screening is typically only performed for female patients. If the female patient
screened positive for the condition, the pregnancy will be at increased risk to be affected.
Prenatal testing through CVS or amniocentesis, or preconception testing using PGD can beconsidered to identify fetus/embryos affected by the condition. Using donor gametes forreproduction is an option as well.

What happens if the Screening Test Results are Negative/Normal?
A negative/normal carrier screening test result= Patient is unlikely to be a carrier; Offspring at decreased risk (not zero) to be affected
Because the detection rate of a carrier screening test typically does not reach 100%, the test
will identify most of the disease carriers but not all. Thus, a negative/normal carrier screen result
lowers the chance an individual is a carrier for that condition, but does not eliminate the risk.
Moreover, new mutations can also arise spontaneously and randomly for each pregnancy.
Therefore, with a screen-negative carrier screen result, the risk to the person’s offspring to beaffected by the screened condition is significantly lowered but not zero.
Post-test counseling for a negative/normal carrier screen result should include a discussionof residual risk--the small chance to still be a carrier and the small chance the offspring can still beaffected by the screened condition, even with a negative/normal carrier screening test result.

Types of Carrier Screening Tests
 Ethnic-based carrier screening: Genetic conditions selected based on the patients’ ethnic

background and focuses only on selected conditions that are more prevalent in that particularethnic population. For examples, Caucasians: Cystic fibrosis, Southeast Asians: Alpha and Betathalassemia, African American: Sickle cell disease, Ashkenazi Jewish: Tay-Sachs disease.
Panethnic carrier screening: A set panel of genetic conditions is offered to all patients
regardless of ethnic background. The panel includes only genetic conditions that have been
acknowledged to be more prevalent in at least one ethnic population.

This newsletter is produced and owned by GGA Corp.
Copyrights © GGA Corp. All Rights Reserved.

GGA Corp. Genetic Counseling Newsletter – Vol. 010
Carrier Screening – ACOG Committee Opinion #690

5

Expanded carrier screening: A set panel of genetic conditions is offered to all patients
regardless of ethnic background. The conditions on the panel are not restricted by ethnicity
and are flexible. They can be ethnic-specific conditions, or conditions that are generally veryrare across all ethnicities. The panel can include as many as over hundreds of genetic
conditions.

ACOG traditionally advocated for ethnic-based screening. However, in this recent committee
opinion, the group states ethnic-based screening, panethnic screening and expanded carrier
screening are all acceptable strategy to be offered for prepregnancy or prenatal carrier screening.
The new stance recognizes recent changes in human ethnic admixture, disease prevalence andadvancement in molecular genetic testing methodology:(1) With multiracial society, it is increasingly difficult to limit a person’s ethnic background andancestry to a single population(2) Particular disorders are less likely to be confined to one specific ethnic group given
increased inter-ethnic marriages(3) The cost of DNA analysis and sequencing has decreased substantially(4) New technology, namely new-generation sequencing (NGS), makes it possible to perform
analysis of multiple genes at the same time at a reasonable cost and time-frame.
At the very basics, ACOG now suggests all patients to be screened for cystic fibrosis, spinal
muscular atrophy, thalassemia and hemoglobinopathies. Fragile X premutation carrier screening
is recommended for women with a family history of fragile X-related disorders or intellectual
disability suggestive of fragile X syndrome, or women with a personal history of ovarian
insufficiency. Additional screening also may be indicated based on family history or specificethnicity.

What are Expanded Carrier Screening Tests?
Simultaneously screen for as many as over hundreds of genetic conditions at the same time
(Disease selection not particularly dictated by ethnicity)
Expanded carrier screen offers the benefit of screening for multiple genetic conditions with
one blood draw within a short time-frame. This is a strategy acceptable by ACOG. This may be
appealing for many patients and providers given the large number of conditions that can beevaluated at once and the reassurance it offers.
However, the limitation and risks of such approach should be considered and discussed withthe patients as well. For example, the more conditions one tests for, the higher the chance that theThis newsletter is produced and owned by GGA Corp.
Copyrights © GGA Corp. All Rights Reserved.

GGA Corp. Genetic Counseling Newsletter – Vol. 010
Carrier Screening – ACOG Committee Opinion #690

6test returns abnormal and he/she is found to be a carrier for a genetic condition. This may increase
the need to test reproductive partners, the need for genetic counseling discussion and patientanxiety. Moreover, with some rare genetic conditions, residual risk calculation after a normal carrier
screen may not be available given limited information on this condition.
The conditions on the expanded carrier screening panel should be carefully selectedconsidering the risks/benefits/limitations as stated above. ACOG suggests the conditions screened
for should meet the following criteria: carrier frequency is 1/100 (1%) or higher, has awell-defined clinical phenotype, have a detrimental effect on quality of life, cause cognitive or
physical impairment, require surgical or medical intervention or have an onset early in life.
Prenatal diagnosis for these conditions should be available. Adult-onset conditions should not beincluded.

Does Carrier Screening Tests Replace the Newborn Screening Tests?
Regardless of parents’ carrier screening test results, newborn screening is still recommended.

Is Carrier Screening Required?
Carrier screening for any condition is optional. All patients may accept or decline testing for
any or all carrier screening tests after counseling discussion regarding risks/benefits/limitation.

【Reference】
American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 690:
Carrier Screening in the Age of Genomic Medicine. Obstet Gynecol. 2017 Mar;129(3):e35-e40.

Do you have any questions related to genetic counseling?
What topics would you like the GGA Genetic Counseling
Newsletter to discuss?
Your suggestions are greatly appreciated so we canfurther improve our newsletter!
Email address of the GGA Genetic Counseling Team
GCSupport@gga.asia

This newsletter is produced and owned by GGA Corp.
Copyrights © GGA Corp. All Rights Reserved.